Page last updated: 2024-10-25

deferoxamine and Bright Disease

deferoxamine has been researched along with Bright Disease in 9 studies

Deferoxamine: Natural product isolated from Streptomyces pilosus. It forms iron complexes and is used as a chelating agent, particularly in the mesylate form.
desferrioxamine B : An acyclic desferrioxamine that is butanedioic acid in which one of the carboxy groups undergoes formal condensation with the primary amino group of N-(5-aminopentyl)-N-hydroxyacetamide and the second carboxy group undergoes formal condensation with the hydroxyamino group of N(1)-(5-aminopentyl)-N(1)-hydroxy-N(4)-[5-(hydroxyamino)pentyl]butanediamide. It is a siderophore native to Streptomyces pilosus biosynthesised by the DesABCD enzyme cluster as a high affinity Fe(III) chelator.

Bright Disease: A historical classification which is no longer used. It described acute glomerulonephritis, acute nephritic syndrome, or acute nephritis. Named for Richard Bright.

Research Excerpts

ExcerptRelevanceReference
" These results indicate that in uremic diabetic patients with lower intake of Al containing drugs, an early accumulation of Al in the whole body occurs possibly because of the enhanced absorption rate of Al at an intestine and/or the low PTH level."1.28[High deposition rate of aluminum in tissues in diabetic hemodialysis patients]. ( Chimata, M; Ideura, T; Iwasaki, S; Kawamura, M; Koshikawa, S; Sudo, M; Yoshimura, A, 1990)
" Since in the dosage used there did not appear any side effects the Desferal-application is to characterized as a distinct and effective technique for the decrease of the serum-aluminium-concentration in patients undergoing dialysis."1.27[Desferal treatment of aluminum poisoning; effect on serum concentrations of aluminum (Al), iron (Fe) and copper (Cu)]. ( Fünfstück, R; Günther, K; Schröter, H; Sperschneider, H; Stein, G; Winnefeld, K, 1986)

Research

Studies (9)

TimeframeStudies, this research(%)All Research%
pre-19908 (88.89)18.7374
1990's1 (11.11)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
SUNDERMANN, A1
PANZRAM, G1
Hood, SA1
Clark, WF1
Hodsman, AB1
Bolton, CF1
Cordy, PE1
Anderson, C1
Leung, F1
Iwasaki, S1
Ideura, T1
Yoshimura, A1
Chimata, M1
Kawamura, M1
Sudo, M1
Koshikawa, S1
Schrijver, G1
Schalkwijk, J1
Robben, JC1
Assmann, KJ1
Koene, RA1
Boyce, NW1
Holdsworth, SR1
Günther, K1
Winnefeld, K1
Stein, G1
Sperschneider, H1
Schröter, H1
Fünfstück, R1
McCarthy, JT1
Kurtz, SB1
McCall, JT1
Ham, KN1
Brown, DJ1
Dawborn, JK1
Johnson, CI1
Nelson, S1
Xipell, JM1
Dittrich, P1
Huber, H1
Stühlinger, W1

Other Studies

9 other studies available for deferoxamine and Bright Disease

ArticleYear
[DISEASES OF THE LUNG].
    Munchener medizinische Wochenschrift (1950), 1964, May-08, Volume: 106

    Topics: Adrenal Cortex Hormones; Child; Deferoxamine; Diagnosis, Differential; Glomerulonephritis; Granuloma

1964
Successful treatment of dialysis osteomalacia and dementia, using desferrioxamine infusions and oral 1-alpha hydroxycholecalciferol.
    American journal of nephrology, 1984, Volume: 4, Issue:6

    Topics: Aluminum; Biopsy; Bone and Bones; Deferoxamine; Dementia; Female; Glomerulonephritis; Hemodialysis,

1984
[High deposition rate of aluminum in tissues in diabetic hemodialysis patients].
    Nihon Jinzo Gakkai shi, 1990, Volume: 32, Issue:6

    Topics: Adult; Aged; Aluminum; Deferoxamine; Diabetic Nephropathies; Female; Glomerulonephritis; Humans; Mal

1990
Antiglomerular basement membrane nephritis in beige mice. Deficiency of leukocytic neutral proteinases prevents the induction of albuminuria in the heterologous phase.
    The Journal of experimental medicine, 1989, Apr-01, Volume: 169, Issue:4

    Topics: Albuminuria; Animals; Basement Membrane; Catalase; Cathepsin G; Cathepsins; Deferoxamine; Glomerulon

1989
Hydroxyl radical mediation of immune renal injury by desferrioxamine.
    Kidney international, 1986, Volume: 30, Issue:6

    Topics: Acute Kidney Injury; Animals; Antibodies; Basement Membrane; Deferoxamine; Dose-Response Relationshi

1986
[Desferal treatment of aluminum poisoning; effect on serum concentrations of aluminum (Al), iron (Fe) and copper (Cu)].
    Zeitschrift fur Urologie und Nephrologie, 1986, Volume: 79, Issue:10

    Topics: Adult; Aluminum; Copper; Deferoxamine; Female; Glomerulonephritis; Humans; Hypertension, Renal; Iron

1986
Elevated bone aluminum content in dialysis patients without osteomalacia.
    Mayo Clinic proceedings, 1985, Volume: 60, Issue:5

    Topics: Adult; Aluminum; Biopsy; Bone and Bones; Deferoxamine; Glomerulonephritis; Histocytochemistry; Human

1985
Dialysis osteomalacia: a possible role for zirconium as well as aluminium.
    Pathology, 1985, Volume: 17, Issue:3

    Topics: Chronic Kidney Disease-Mineral and Bone Disorder; Deferoxamine; Glomerulonephritis; Humans; Osteomal

1985
[Studies on clearance of Fe59-tagged desferrioxamine in healthy kidney function and kidney diseases].
    Wiener klinische Wochenschrift, 1966, Jul-01, Volume: 78, Issue:26

    Topics: Aminohippuric Acids; Deferoxamine; Glomerulonephritis; Humans; Iron Isotopes; Kidney; Kidney Functio

1966